Oneview Healthcare

Digital Transformation Will Expand Interoperable Patient Care Systems

AnalystHighTarget

Not Invested

Consensus Narrative from 3 Analysts

Published

12 Aug 25

Updated

12 Aug 25

AnalystHighTarget's Fair Value

AU$0.57

63.3% undervalued

12 Aug

AU$0.21

-46.2%

-12.5%

Author's Valuation

AU$0.6

63.3% undervalued

AnalystHighTarget Fair Value

Narrative

Updates0

AnalystHighTarget Fair Value

AU$0.6

63.3% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

26.62%

Healthtech revenue growth rate

4.12%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

8.35%

Calculation

€1.06m

Earnings '28

412.63x

PE Ratio '28

€437.22m

Market Cap '28

€437.22m

Market Cap '28

1.08b

No. shares '28

€0.41

Share Price '28

€0.41 Share Price '28

Discounted to 2025 @ 8.34% p.a.

€0.32

Fair Value '25

€0.32 Fair Value '25

Converted to AUD @ 1.7893 EUR/AUD Exchange Rate

AU$0.57

Fair Value '25